Literature DB >> 23798430

Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b.

Graziella Curtale1, Massimiliano Mirolo, Tiziana Ada Renzi, Marzia Rossato, Flavia Bazzoni, Massimo Locati.   

Abstract

Toll-like receptors (TLRs) play key roles in detecting pathogens and initiating inflammatory responses that, subsequently, prime specific adaptive responses. Several mechanisms control TLR activity to avoid excessive inflammation and consequent immunopathology, including the anti-inflammatory cytokine IL-10. Recently, several TLR-responsive microRNAs (miRs) have also been proposed as potential regulators of this signaling pathway, but their functional role during the inflammatory response still is incompletely understood. In this study, we report that, after LPS engagement, monocytes up-regulate miR-146b via an IL-10-mediated STAT3-dependent loop. We show evidence that miR-146b modulates the TLR4 signaling pathway by direct targeting of multiple elements, including the LPS receptor TLR4 and the key adaptor/signaling proteins myeloid differentiation primary response (MyD88), interleukin-1 receptor-associated kinase 1 (IRAK-1), and TNF receptor-associated factor 6 (TRAF6). Furthermore, we demonstrate that the enforced expression of miR-146b in human monocytes led to a significant reduction in the LPS-dependent production of several proinflammatory cytokines and chemokines, including IL-6, TNF-α, IL-8, CCL3, CCL2, CCL7, and CXCL10. Our results thus identify miR-146b as an IL-10-responsive miR with an anti-inflammatory activity based on multiple targeting of components of the TLR4 pathway in monocytes and candidate miR-146b as a molecular effector of the IL-10 anti-inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23798430      PMCID: PMC3710884          DOI: 10.1073/pnas.1219852110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  The emerging role of microRNA in regulation of endotoxin tolerance.

Authors:  Edel M Quinn; JiangHuai Wang; Henry P Redmond
Journal:  J Leukoc Biol       Date:  2012-02-28       Impact factor: 4.962

Review 2.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

Review 3.  MicroRNA regulation of innate immune responses in epithelial cells.

Authors:  Rui Zhou; Steven P O'Hara; Xian-Ming Chen
Journal:  Cell Mol Immunol       Date:  2011-07-04       Impact factor: 11.530

4.  Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression.

Authors:  E M Benkhart; M Siedlar; A Wedel; T Werner; H W Ziegler-Heitbrock
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

5.  Regulation of monocyte functional heterogeneity by miR-146a and Relb.

Authors:  Martin Etzrodt; Virna Cortez-Retamozo; Andita Newton; Jimmy Zhao; Aylwin Ng; Moritz Wildgruber; Pedro Romero; Thomas Wurdinger; Ramnik Xavier; Frederic Geissmann; Etienne Meylan; Matthias Nahrendorf; Filip K Swirski; David Baltimore; Ralph Weissleder; Mikael J Pittet
Journal:  Cell Rep       Date:  2012-04-19       Impact factor: 9.423

6.  Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins.

Authors:  P K Murthy; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits.

Authors:  Antonio Recchiuti; Sriram Krishnamoorthy; Gabrielle Fredman; Nan Chiang; Charles N Serhan
Journal:  FASEB J       Date:  2010-10-18       Impact factor: 5.191

8.  Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.

Authors:  Steve Alas; Benjamin Bonavida
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

9.  IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes.

Authors:  Marzia Rossato; Graziella Curtale; Nicola Tamassia; Monica Castellucci; Laura Mori; Sara Gasperini; Barbara Mariotti; Mariacristina De Luca; Massimiliano Mirolo; Marco A Cassatella; Massimo Locati; Flavia Bazzoni
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

10.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.

Authors:  Mark P Boldin; Konstantin D Taganov; Dinesh S Rao; Lili Yang; Jimmy L Zhao; Manorama Kalwani; Yvette Garcia-Flores; Mui Luong; Asli Devrekanli; Jessica Xu; Guizhen Sun; Jia Tay; Peter S Linsley; David Baltimore
Journal:  J Exp Med       Date:  2011-05-09       Impact factor: 14.307

View more
  125 in total

1.  Anti-tumoral effects of miR-3189-3p in glioblastoma.

Authors:  Duane Jeansonne; Mariacristina DeLuca; Luis Marrero; Adam Lassak; Marco Pacifici; Dorota Wyczechowska; Anna Wilk; Krzysztof Reiss; Francesca Peruzzi
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

2.  Ablation of miR-146b in mice causes hematopoietic malignancy.

Authors:  Takahiro Mitsumura; Yoshiaki Ito; Tomoki Chiba; Takahide Matsushima; Ryota Kurimoto; Yoko Tanaka; Tomomi Kato; Keisuke Uchida; Takashi Ito; Kouhei Yamamoto; Yoshinobu Eishi; Masanobu Kitagawa; Yasunari Miyazaki; Naohiko Inase; Hiroshi Asahara
Journal:  Blood Adv       Date:  2018-12-11

3.  miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.

Authors:  Helen Hermann; Toomas Runnel; Alar Aab; Hansjörg Baurecht; Elke Rodriguez; Nathaniel Magilnick; Egon Urgard; Liisi Šahmatova; Ele Prans; Julia Maslovskaja; Kristi Abram; Maire Karelson; Bret Kaldvee; Paula Reemann; Uku Haljasorg; Beate Rückert; Paulina Wawrzyniak; Michael Weichenthal; Ulrich Mrowietz; Andre Franke; Christian Gieger; Jonathan Barker; Richard Trembath; Lam C Tsoi; James T Elder; Eric R Tkaczyk; Kai Kisand; Pärt Peterson; Külli Kingo; Mark Boldin; Stephan Weidinger; Cezmi A Akdis; Ana Rebane
Journal:  J Invest Dermatol       Date:  2017-06-06       Impact factor: 8.551

4.  Similar miRNomic signatures characterize the follicular fluids collected after follicular and luteal phase stimulations in the same ovarian cycle.

Authors:  Danilo Cimadomo; Ramona Carmelo; Elvira Immacolata Parrotta; Stefania Scalise; Gianluca Santamaria; Erminia Alviggi; Maria Teresa De Angelis; Gianmarco Sarro; Alberto Vaiarelli; Roberta Venturella; Laura Rienzi; Fulvio Zullo; Filippo Maria Ubaldi; Giovanni Cuda
Journal:  J Assist Reprod Genet       Date:  2019-11-07       Impact factor: 3.412

Review 5.  Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.

Authors:  Michael J Lacagnina; Phillip D Rivera; Staci D Bilbo
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

6.  The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Authors:  Didem Ağaç; Leonardo D Estrada; Robert Maples; Lora V Hooper; J David Farrar
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

Review 7.  Diversity, Mechanisms, and Significance of Macrophage Plasticity.

Authors:  Massimo Locati; Graziella Curtale; Alberto Mantovani
Journal:  Annu Rev Pathol       Date:  2019-09-17       Impact factor: 23.472

Review 8.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4.

Authors:  Yan-Ni Lv; Ai-Jun Ou-Yang; Long-Sheng Fu
Journal:  Cell Mol Neurobiol       Date:  2016-03-12       Impact factor: 5.046

10.  Association of microRNA 146 with middle ear hyperplasia in pediatric otitis media.

Authors:  Tina L Samuels; Justin Yan; Pawjai Khampang; Alexander MacKinnon; Wenzhou Hong; Nikki Johnston; Joseph E Kerschner
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-07-02       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.